Thromboxane-induced pulmonary vasoconstriction: Involvement of calcium

I. S. Farrukh, J. R. Michael, W. R. Summer, N. F. Adkinson, G. H. Gurtner

Research output: Contribution to journalArticlepeer-review


Infusion of tert-butyl hydroperoxide (t-bu-OOH) or arachidonic acid into rabbit pulmonary arteries stimulated thromboxane B2 (TxB2) production and caused pulmonary vasoconstriction. Both phenomena were blocked by cyclooxygenase inhibitors or a thromboxane synthase inhibitor. The increase in pulmonary arterial pressure caused by either t-bu-OOH or arachidonic acid infusion correlated with the concentration of TxB2 in the effluent perfusate. The concentration of TxB2 in the effluent perfusate, however, was always 10-fold greater after arachidonic acid infusion. In the rabbit pulmonary vascular bed lipoxygenase products did not appear involved in the vasoactive response to t-bu-OOH or exogenous arachidonic acid infusion. Calcium entry blockers or a calcium-free perfusate prevented the thromboxane-induced pulmonary vasoconstriction. Calmodulin inhibitors also blocked the pulmonary vasoconstriction induced by t-bu-OOH without affecting the production of TxB2 or prostacyclin. These results suggest that thromboxane causes pulmonary vasoconstriction by increasing cytosol calcium concentration.

Original languageEnglish (US)
Pages (from-to)34-44
Number of pages11
JournalJournal of applied physiology
Issue number1
StatePublished - Jan 1 1985
Externally publishedYes

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)


Dive into the research topics of 'Thromboxane-induced pulmonary vasoconstriction: Involvement of calcium'. Together they form a unique fingerprint.

Cite this